Performance of a quantitative human immunodeficiency virus type 1 p24 antigen assay on various HIV-1 subtypes for the follow-up of human immunodeficiency type 1 seropositive individuals

被引:27
|
作者
Ribas, SG
Ondoa, P
Schüpbach, J
van der Groen, G
Fransen, K
机构
[1] Inst Trop Med, B-2000 Antwerp, Belgium
[2] Univ Zurich, Swiss Natl Ctr Retroviruses, Zurich, Switzerland
关键词
HIV-1; RNA; viral load; heat-denatured p24 antigen; HIV subtypes;
D O I
10.1016/S0166-0934(03)00219-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The heat-denatured signal-amplified p24 antigen assay is a low-cost test allowing the determination of plasma levels of HIV-1 p24 antigen in infected patients. This assay may be appropriate for monitoring disease progression in HIV seropositive patients in developing countries. Only a few data on the clinical validation of the test are available for HIV-1 non-subtypes B viruses that represent the vast majority of virus circulating in Africa. The present study was undertaken to evaluate and compare the performance of a heat-denatured signal-amplified p24 assay for the determination of p24 viral load in the plasma of individuals infected with different subtypes of HIV-1 and using the RT-PCR-based RNA viral load test as the gold standard. A total of 120 plasma samples from individuals infected with HIV-1 strains belonging to group M (subtypes A --> H) and group O, as well as recombinant strains, were tested in parallel with the heat-denatured signal-amplified p24 assay and the RNA viral load. Plasma p24 levels appeared to be correlated significantly with the plasma RNA viral loads (R = 0.751, P < 0.0001). The heat-denatured p24 antigen assay was capable of measuring the plasma level of p24 derived from all the HIV-1 subtypes and recombinants selected for this study, in contrast to the RNA viral load test which lacked sensitivity towards HIV-1 group O. The heat-denatured signal-amplified p24 assay is a reliable, sensitive and a more affordable tool that can be used for the follow-up of patients infected with B and non-B subtypes as well as recombinant forms of HIV-1 in developing countries. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:29 / 34
页数:6
相关论文
共 50 条
  • [41] In vitro p24 antigen-stimulated lymphocyte proliferation and β-chemokine production in human immunodeficiency virus type 1 (HIV-1)-seropositive subjects after immunization with an inactivated gp120-depleted HIV-1 immunogen (Remune)
    Moss, RB
    Wallace, MR
    Lanza, P
    Giermakowska, W
    Jensen, FC
    Theofan, G
    Chamberlin, C
    Richieri, SP
    Carlo, DJ
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1998, 5 (03) : 308 - 312
  • [42] Glycoprotein 96-Mediated Presentation of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Human Leukocyte Antigen Class I-Restricted Peptide and Humoral Immune Responses to HIV-1 p24
    Gong, XiaoYan
    Gai, WeiWei
    Xu, JunQiang
    Zhou, Wei
    Tien, Po
    CLINICAL AND VACCINE IMMUNOLOGY, 2009, 16 (11) : 1595 - 1600
  • [43] Evaluation of the Abbott LCx HIV-1 RNA quantitative, a new assay for quantitative determination of human immunodeficiency virus type 1 RNA
    Zanchetta, N
    Nardi, G
    Tocalli, L
    Drago, L
    Bossi, C
    Pulvirenti, FR
    Galli, C
    Gismondo, MR
    JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (10) : 3882 - 3886
  • [44] Cognitive slowing in asymptomatic individuals who are seropositive for human immunodeficiency virus type 1
    Amador, F
    Mayor-Ríos, J
    del Castillo-Martín, N
    REVISTA DE NEUROLOGIA, 2006, 42 (03) : 132 - 136
  • [45] Human Immunodeficiency Virus Type 1 (HIV-1) Infects Human Brain Pericytes In Vitro
    Nakagawa, S.
    Toborek, M.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2011, 6 : S18 - S18
  • [46] COMPARISON OF CORE ANTIGEN (P24) ASSAY AND REVERSE-TRANSCRIPTASE ACTIVITY FOR DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 REPLICATION
    LAND, S
    BEATON, F
    MCPHEE, DA
    GUST, ID
    JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (03) : 486 - 489
  • [47] A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) INFECTION-ENHANCING FACTOR IN SEROPOSITIVE SERA
    ROBINSON, WE
    MONTEFIORI, DC
    MITCHELL, WM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 149 (02) : 693 - 699
  • [48] Treatment-induced decline of human immunodeficiency virus-1 p24 and HIV-1 RNA in lymphoid tissue of patients with early human immunodeficiency virus-1 infection
    Kuster, H
    Opravil, M
    Ott, P
    Schlaepfer, E
    Fischer, M
    Günthard, HF
    Lüthy, R
    Weber, R
    Cone, RW
    AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (06): : 1973 - 1986
  • [49] Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes
    Chawla, A.
    Murphy, G.
    Donnelly, C.
    Booth, C. L.
    Johnson, M.
    Parry, J. V.
    PhillipS, A.
    Geretti, A. M.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (02) : 415 - 420
  • [50] Evaluation of a Highly Sensitive Qualitative Human Immunodeficiency Virus Type 1 (HIV-1) RNA Assay for Detection of HIV-1 Suppression
    Nugent, C. Thomas
    Nodelman, Vladislav
    Giachetti, Cristina
    Richman, Douglas D.
    Looney, David J.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (03) : 833 - 836